---
source: Clinical Veterinary Advisor_ Do - Etienne Cote.pdf
pages: 3846
converted: 2026-02-04 00:48
part: chunk_046
estimated_tokens: 4278
---


HM


100, 250 mg T


HM


1000 IU/mL I


VM



17 de 81 30-09-2011 22:56


Introduction to Drug Formulary http://www.clinicalvetadvisor2.com/html/bc/ch001s0019_s001.php#ch0...


Generic Name (Trade How the Drug
Name) Indications/Drug Type Canine Dose Feline Dose Comments Is Supplied



Cimetidine (Tagamet) H2 receptor antagonist,
esophagitis, gastric reflux,
chronic gastritis, GI tract
ulceration,
hypergastrinemia, effects
of mast cell tumors


Ciprofloxacin (Cipro, Fluoroquinolone
Ciloxan) antibacterial agent, broadspectrum “cidal”;
Mycoplasma


Cisapride (Propulsid, Prokinetic serotonergic for
Prepulsid) feline megacolon;
gastroesophageal reflux;
first- and second-degree
GI motility disorders



5-10 mg/kg PO q 6-12 2.5-5 mg/kg PO Hepatic microsomal
h; 5 mg/kg IV q 8 h q 8-12 h enzyme inhibitor;
administer slowly IV


5-15 mg/kg PO q 12 h - Incompletely
bioavailable in dogs;
see other
fluoroquinolone
comments under
Enrofloxacin



0.1-0.5 mg/kg PO q Per cat: 2.5-5
8-12 h mg total dose
PO q 8-12 h



Requires adjunctive
Tx as stool softener,
does not increase
gastric secretions;
increases esophageal
peristalsis; reported
to be associated with
ventricular
arrhythmias in HM
and no longer
available on the
human market; toxic
interaction with
ketoconazole,
cimetidine, macrolide
antibiotics



200, 300, 400,
800 mg T; 60
mg/ mL S; 150
mg/mL I HM


100, 250, 500,
750 mg T


HM


10, 20 mg T; 1
mg/ mL S


HM


10 and 50 mg
vials I HM



Cisplatin (Platinol) Solid carcinomas, 50-70 mg/m `[2]` IV every
osteosarcoma 3-5 weeks; pretreat
with IV fluids 12 hours
before and after Tx.
Intracavitary: same
protocol, using 50
mg/m `[2]` dose diluted into
250 mg 0.9% sterile
NaCl and administered
into the peritoneal or
pleural space
immediately after
effusion evacuation


Citracal (see calcium citrate)


Citrate (see potassium citrate)


Claforan (see cefotaxime)



None: do not Use antiemetic agent;
use BM suppression;
renal toxicity; fatal
pulmonary edema in
cats; anaphylaxis; use
chemo precautions
when handling or
administering



Clarithromycin (Biaxin) Broad-spectrum macrolide
antibacterial; resistant
respiratory or skin
infections


Clavamox (see amoxicillin/clavulanic
acid)



5-10 mg/kg PO q 12 h Same GI, liver disturbances; 250, 500, mg T;
BM toxicity rarely 25, 50 mg/mL S


HM



Clemastine fumarate (Tavist
products, Contac products,
many others)



Antihistamine; allergic skin
disease, other allergies,
mast cell tumor



0.05-0.1 mg/kg PO q 0.3-0.6 mg/cat Lethargy/drowsiness
12 h PO q 12 h or restlessness;
caution: other active
ingredients in OTC
combo formulations



Cleocin (see clindamycin)


Clindamycin (Cleocin, Lincosamide antibiotic,
Antirobe) G+, Streptococcus,
Staphylococcus,



5-10 mg/kg PO q 12 h;
toxoplasmosis: 5-20
mg/kg PO q 12 h



Same;
toxoplasmosis:
12.5-25 mg/kg
PO q 12 h



May cause V/D and
very rarely
hepatotoxicity; do not
use with erythromycin



1.34, 2.8 mg T


HM OTC


150 mg/mL I: 25,
75, 150 mg C; 25
mg/mL S



18 de 81 30-09-2011 22:56


Introduction to Drug Formulary http://www.clinicalvetadvisor2.com/html/bc/ch001s0019_s001.php#ch0...


Generic Name (Trade How the Drug
Name) Indications/Drug Type Canine Dose Feline Dose Comments Is Supplied



anaerobes, Bacteroides,
toxoplasmosis,
neosporosis, babesiosis,
osteomyelitis


Clofazimine (Lamprene) Mycobacterial infections 1 mg/kg PO q
24 h up to daily
maximum of 4
mg/kg


Clomicalm (see clomipramine)



or chloramphenicol;
oral solution has
unpleasant taste


Efficacy and safety
poorly established in
VM



Clomipramine (Anafranil, Separation anxiety, acral
Clomicalm) lick dermatitis; tricyclic
antidepressant agent



1-2 mg/kg PO q 12 h 0.5-1 mg/kg PO Do not use in
q 24 h breeding dogs or if
dog is receiving or
has received MAO
inhibitors (e.g.,
Anipryl, amitraz, etc.);
vomiting, lethargy,
diarrhea, and
polydipsia are
adverse reactions
most often noted;
caution in animals with
GI motility or seizure
disorders



Clonazepam (Klonopin) Seizure disorders, panic 0.5 mg/kg PO q 8-12
disorders, sedation h; titrate as required to
effect



`1` /8-¼ of 0.5 mg
tablet PO as
feline appetite
stimulant



Second-line seizure
Tx; sedation, duration
of action in dogs may
be short (few hours)



VM, HM


50, 100 mg C


HM


5, 20, 40, 80 mg
T


VM


0.5, 1, 2 mg T


HM


75 mg T HM


250 mcg/mL I


VM


3.75, 7.5, 15 mg
T


HM


10 mg/mL
topical solution
OTC, HM



Clopidogrel (Plavix) Antiplatelet drug, - 18.75 mg/cat Emerging application
thienopyridine drug PO q 24 h in cats at risk of
thromboembolism.
Clinical efficacy/safety
promising but
unproven.



Cloprostenol (Estrumate) Abortifacient for mismating
(early, prior to ossification
of fetal bones)


Clorazepate (Tranxene) Second- or third-line
antiepileptic drug;
benzodiazepine


Clotrimazole (Veltrim, Used topically for nasal
Lotrimin, Mycelex) aspergillosis; also
externally for Malassezia
and other fungi


Coal tar (0.5% to 8%) Shampoo; cornification
disorders/seborrhea,
dermatitis, eczema,
keratolytic


Cobalamin (vitamin B12, Used for treating vitamin
cyanocobalamin) B12 deficiency from
exocrine pancreatic
disease, SIBO, and in
giant schnauzers



1-2.5 mcg/kg SQ, q Same Dilute 1:10 with sterile
24-48 h for 5 days 0.9% NaCl for
accurate dosing


0.5-1 mg/kg PO q 8 h 0.5-1 mg/kg PO New agent; safety
q 8 h and efficacy profile
poorly defined at this
time



PRN to fill nasal cavity for
nasal aspergillosis (follow
precautions and protocol)


See p. 1308


Bathe every 3-14 days;
leave in contact with
skin for 10 minutes and
rinse thoroughly


Total dose: 250-1200
mcg (0.25-0.12 mg)
per dog, SQ once
weekly × 6 weeks,
then q 14 d × 6 weeks,
then PRN



Total dose:
125-250 mcg
(0.125-0.25 mg)
per cat IM, SQ;
dosing schedule
as for dogs




- Intranasal
administration
requires preplacing
catheters surgically or
via endoscope; use
propylene glycol
preparation for this
indication



Same May irritate skin VM



1000 mcg/mL (= 1
mg/mL) I


HM, VM



19 de 81 30-09-2011 22:56


Introduction to Drug Formulary http://www.clinicalvetadvisor2.com/html/bc/ch001s0019_s001.php#ch0...


Generic Name (Trade How the Drug
Name) Indications/Drug Type Canine Dose Feline Dose Comments Is Supplied



Codeine Opiate antitussive 1-2 mg/kg PO PRN up May cause sedation
to q 6 h at higher doses;
schedule C-II


Cogentin (see benztropine)


Colace (see dioctyl sodium
sulfosuccinate)


Colchicine Hepatic fibrosis 0.03 mg/kg/day PO q No reported use Not well described;
24 h GI effects, BM
toxicity, teratogenicity
possible


Colony-stimulating factor (see filgrastim)


Comfortis (see spinosad)


Compazine (see prochlorperazine)


Conofite (see miconazole)


Convenia (see cefovecin)


Cordarone (see amiodarone)


Coreg (see carvedilol)


Corid (see amprolium)


Corticotropin (see ACTH gel)


Cortrosyn (see ACTH-like solution,
aqueous)


Cosequin (see glucosaminechondroitin sulfate)


Cosmegen (see actinomycin D)


Cosyntropin (see ACTH-like solution,
aqueous)


Coumadin (see warfarin)


Covera (see verapamil)


Cuprimine (see penicillamine)


Cyanocobalamin (see cobalamin)



Same GI signs; BM
suppression;
hemorrhagic cystitis,
especially with higher
(weekly) dose;
alopecia; use with
caution; use chemo
precautions when
handling or
administering (see
Chemotherapy;
Adverse Reactions, p.
188); do not crush or
break tablets.
Caution: cyclosporine
brand name almost
identical (Neosar
versus Neoral)


Do not use May be ophthalmic
irritant; monitor for
infections



Cyclophosphamide Lymphoreticular tumors,
(Cytoxan, Neosar) solid carcinomas, immunemediated disease



50 mg/m `[2]` (or 2 mg/kg)
PO, 4 days on, 3 days
off, or use q 48 h; or

200-300 mg/m `[2]` IV q 3
weeks


See pp. 671, 677 for
body surface area to
body weight conversion
chart.



15, 30, 60 mg T 3
mg/mL S


HM


0.5, 0.6 mg T


HM


25, 50 mg T; 100,
200, 500 mg and
1 and 2 g vials I


HM


HM, VM, OO,
OS; 4 mL olive
oil and 1 mL
cyclosporine



Cyclosporine-ophthalmic T-lymphocyte inhibitor; 0.2% ophthalmic
(Optimmune) KCS in dogs ointment or solution in
oil base; use one
drop/short (¼-in) strip



20 de 81 30-09-2011 22:56


Introduction to Drug Formulary http://www.clinicalvetadvisor2.com/html/bc/ch001s0019_s001.php#ch0...


Generic Name (Trade How the Drug
Name) Indications/Drug Type Canine Dose Feline Dose Comments Is Supplied


q 12 h in affected
eye(s) until
improvement occurs,
then q 24 h



Cyclosporine-systemic
(Sandimmune, Atopica,
Neoral)



IHA, ITP, perianal fistula,
atopic dermatitis, feline
necrotizing gingivitis, renal
transplantation, other
immunosuppressive
purposes



Emulsion forms:
(Neoral, Atopica): 2-5
mg/kg PO q 12 h (2-5
mg/kg PO q 24 h if
concurrent
ketoconazole
administration)
Nonemulsion form:
(Sandimmune, very
rarely available now):
5-10 mg/kg PO q 12 h
(5-10 mg/kg PO q 24 h
if concurrent
ketoconazole
administration) 2-3
mg/kg slow IV over 4
hours q 12 h; dilute to
1 mg/mL in D5W or
0.9% NaCl before IV
administration



Same; cats
should have a
negative
Toxoplasma
titer to qualify
for treatment



25, 50, 100 mg
C; 100 mg/mL
S; 50 mg/mL I,
HM; 10, 25, 50,
100 mg C VM


4 mg T; 0.4
mg/mL S


HM


100, 500 mg, 1
and 2 g vials I


HM


100, 200 mg
vials, I



Cypip (see diethylcarbamazine)


Cyproheptadine (Periactin) Serotonin and H1 antagonist:
Appetite stimulant via
hypothalamic action


Feline pica


Antihistamine


Urine spraying


Add-on for feline asthma


Cystorelin (see gonadotropinreleasing hormone)


Cytarabine (see cytosine arabinoside)


Cytobin (see triiodothyronine)


Cytomel (see triiodothyronine)


Cytosar (see cytosine arabinoside)



1 mg/kg PO q 8-12 h Total dose = 1-4
mg/ cat PO q
12-24 h



Adjust dose to attain
good clinical response
and 200-500 ng/mL
blood level (for
autoimmune diseases;
300-800 ng/mL for
renal transplant
patients). Oral doses
based on greater
absorption of
emulsion forms versus
nonemulsion forms;
can cause
nephrotoxicity
(protein-losing
nephropathy), gingival
hyperplasia;
anaphylaxis possible
with IV; little clinical
experience with IV to
date. Caution:
cyclophosphamide
brand name is almost
identical (Neoral
versus Neosar)


Can cause excitability
or depression,
especially at higher
doses; vomiting,
aggressiveness



Cytosine arabinoside
(Cytarabine, Cytosar,
ARA-C)



Antineoplastic, lymphoma 100 mg/m `[2]` SQ or slow Same Leukopenia-BM
protocol IV q 24 h for 2-4 days suppression, GI
toxicity, reconstituted
vial good for 48
hours; use along with
cancer protocol; use
chemo precautions
when handling or
administering



Cytotec (see misoprostol)


Cytoxan (see cyclophosphamide)


Dacarbazine (DTIC) Melanoma, sarcoma 800-1000 mg/m `[2]` IV,
CRI (8 hours) every
3-4 weeks



Not GI toxicity, BM
recommended suppression,
extravasation injury



21 de 81 30-09-2011 22:56


Introduction to Drug Formulary http://www.clinicalvetadvisor2.com/html/bc/ch001s0019_s001.php#ch0...


Generic Name (Trade How the Drug
Name) Indications/Drug Type Canine Dose Feline Dose Comments Is Supplied


HM


Dactinomycin (see actinomycin D)


Dalteparin (see heparin,
low-molecular-weight)



Danazol (Danocrine) Modified androgen; used
for ITP, IHA; anabolic;
used for prostatic
hypertrophy or androgendependent neoplasia


Danocrine (see danazol)



5-10 mg/kg PO q 12 h 5 mg/kg PO q Adjunctive Tx for ITP
12 h and IHA;
hepatotoxicity; BM
toxicity possible;
immunosuppressive
response may take
weeks or months;
androgen effects
faster



50, 100, 200 mg
C


HM



Dantrolene (Dantrium) Skeletal muscle relaxant; 2-3 mg/kg IV; 1-5 mg/ 0.5-2 mg/kg PO 100 mg C 0.33
malignant hyperthermia kg PO q 8 h q 12 h mg/ mL I


HM



Dapsone (Avlosulfon) 1. Antibacterial,
antiinflammatory
agent used for some
skin disorders



1. 1 mg/kg PO q 8 h Rarely used in

2. 1 mg/kg PO q 8 h this species; 1

initially until mg/kg PO q 24
remission, then h and 8 mg/kg
0.3 mg/kg

PO q 24 h have

maintenance

been reported



Hepatotoxicity and
BM suppression may
occur early in therapy;
hemolysis, GI signs,
skin eruptions
possible



25 and 100 mg T


HM


25, 40, 60, 100,
150, 200, 300,
500 mcg vials or
preloaded
syringes I


HM


6% preparation
(60 g
decoquinate per
kg of product)
oral premix


VM


500 mg vials I


HM



2.



Antiprotozoal/
antimycobacterial
effects



Daranide (see dichlorphenamide)


Daraprim (see pyrimethamine)


Darbepoetin (Aranesp) Erythropoietin analog;
considered less antigenic;
anemia of chronic kidney
disease


DDAVP (see desmopressin
acetate)


DDVP (see dichlorvos)


DEC (see diethylcarbamazine)


Decadron (see dexamethasone)


Deca-Durabolin (see nandrolone
decanoate)


Decholin (see dehydrocholic acid)



0.45 mcg/kg SQ once
weekly at first, then q
2-3 weeks adjusted for
maintenance



Same Considered less
antigenic in dogs and
cats than recombinant
human erythropoietin


Administer for 2
years, or until PCR
testing is negative, to
inhibit development of
merozoites released
from tissue cysts


- Arrhythmia,
hypotension,
wheezing if CRI too
rapid; hypocalcemia,
thrombocytopenia
possible; do not use



Decoquinate (Deccox) Hepatozoonosis 20 mg/kg (or 1
teaspoon/10 kg mixed
in food) PO q 12 h


Dectomax (see doramectin)


Deferoxamine (Desferal, Iron chelator; treatment of 10-15 mg/kg/hr IV CRI,
DFO) iron toxicity then titrate based on
serum iron levels.
Alternatively, if CRI not
possible, give 10-40
mg/kg IM q 8 h for



22 de 81 30-09-2011 22:56


Introduction to Drug Formulary http://www.clinicalvetadvisor2.com/html/bc/ch001s0019_s001.php#ch0...


Generic Name (Trade How the Drug
Name) Indications/Drug Type Canine Dose Feline Dose Comments Is Supplied


24-72 hours, based on in cases of renal
serum iron levels failure; potential
teratogen


Dehydrocholic acid Used to stimulate bile flow 10-15 mg/kg PO q 8 h Same Do not use with biliary HM
(Decholin) for 7-10 days obstruction



Delmadinone (Tardak) Benign prostatic 1.5 mg/kg IM or SQ: 2
hyperplasia injections 8 days apart;
may repeat 1 dose 1
month later


Demadex (see torsemide)


Demerol (see meperidine HCl)


Denosyl (see methionine,
S-adenosyl)


Depakene (see valproic acid)


Depakote (see valproic acid)


Depen (see penicillamine)


Depo-Medrol (see methylprednisolone
acetate)


Depo-Provera (see
medroxyprogesterone
acetate)


Deprenyl (see selegiline)



Remission of clinical 10 mg/mL I
signs in 83% of dogs.

VM


- GI signs (vomiting, 25, 75, 100 mg
anorexia) chewable T


VM




- Titrate dosage to
effect; monitor serum
electrolytes; no
glucocorticoid activity;
may require oral
prednisolone 0.2-0.4
mg/kg per day as
adjunctive therapy



Deracoxib (Deramaxx) COX-2-inhibiting NSAID
drug; for treatment of
osteoarthritis,
perioperative pain
management


Deramaxx (see deracoxib)


Dermathycin (see thyrotropin)


Derm caps (see fatty acid nutritional
supplement)


DES (see diethylstilbestrol)


Desferal (see deferoxamine)


Desitin (see zinc oxide)


Desmopressin acetate Vasopressin analog
(DDAVP) (1-desamino-8-D-argininevasopressin) to manage
central diabetes insipidus,
von Willebrand disease



Oral dose:
0.25-0.5 mg/cat
PO q 8-12 h
(tablets)



Rhinorrhea,
hypersensitivity
reactions, water
retention; use nasal
spray form topically
(1.5-4 mcg/drop); 40
times stronger than
parenteral (4
mcg/mL)



Desoxycorticosterone
pivalate (DOCP)
(Percorten-V)



Replacement therapy for
mineralocorticoid
deficiency
(hypoadrenocorticism);
each 25 mg releases 1 mg
DOCA/day for 21-26 days



1-2 mg/kg PO q 24 h
(long-term use); 3-4
mg/kg PO q 24 h (max
7 days)


1-4 drops intranasally
or in subconjunctival
sac, q 6-24 h (diabetes
insipidus) or 1-2
mcg/kg SQ, q 24 h to q
12 h; 0.1 mg/kg PO q
8 h (tablets)


1 mL/12 kg, q 25 days
(i.e., 2 mg/kg) IM or
SQ



10 mcg/spray (=
0.1 mL) in 2.5- or
5-mL bottles; 4
mcg/mL I; 0.1 and
0.2 mg, T


HM


25 mg/mL I


VM



23 de 81 30-09-2011 22:56


Introduction to Drug Formulary http://www.clinicalvetadvisor2.com/html/bc/ch001s0019_s001.php#ch0...


Generic Name (Trade How the Drug
Name) Indications/Drug Type Canine Dose Feline Dose Comments Is Supplied



Dexamethasone (Azium,
Dexate, Decadron);
Dexamethasone sodium
phosphate (SP)


Dexasporin ophthalmic
solution or ointment
(Maxitrol)



Potent glucocorticoid for
antiinflammatory, immune
suppression,
hypoadrenocorticism,
shock, pituitary-adrenal
axis testing


Neomycin, polymyxin, and
dexamethasone
combination used for
steroid-responsive
ophthalmic inflammation
where a combined
antibiotic is desirable



1 drop in affected eye 1 drop in
q 6-12 h affected eye q
6-12 h



Antiinflammatory:
0.1-0.2 mg/kg per day
PO, SQ, or IV;
immunosuppressive:
0.2-0.4 mg/kg per day
PO, SQ, or IV;
long-term oral: q 48 h
best.
Hypoadrenocorticism:
0.1-0.8 mg/kg IV (initial
treatment; e.g.,
hypovolemic shock),
but maintenance =
<0.1 mg/kg PO PRN
up to q 24 h. LDDST =
0.01 mg/kg IV; HDDST
= 0.1 mg/kg IV



Same HPA axis suppression,
multiorgan steroid
effects; very high
CNS doses (e.g., 4-8
mg/ kg) of unproven
clinical benefit and
almost always
associated with
short-term adverse
effects (e.g., severe
GI bleeding): if more
than several
consecutive days of
treatment, taper dose
gradually before
stopping

